"北九州市八幡西区北筑（筑豊電気鉄道筑豊電気鉄道線 今池駅から徒歩10分）の内科医院です。 糖尿病を中心とした生活習慣病（高血圧症、高脂血症、メタボリック・シンドロームなど）を対象としたクリニックです。 北九州市八幡を中心に小倉、遠賀・中間、筑豊地域の糖尿病患者さんにより良い医療を提供できるよう努力いたします。 また、日本消化器病学会認定消化器病専門医（医師：廣畑佳秀）・日本消化器内視鏡学会認定消化器内視鏡専門医（医師：廣畑佳秀）として経鼻内視鏡（負担を軽減した胃カメラ）を用いた、胃がんの早期発見に努めます。"

During the past decade, Hirohata Naika Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hirohata Naika Clinic" are "Chronic Kidney Disease" (1 trials), "Diabetic Retinopathy" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Hirohata Naika Clinic" in a lesser frequency.

Most popular intervention types in "Hirohata Naika Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin" (1 trials), "Finerenone (BAY94-8862)" (1 trials), "Finerenone (Kerendia, BAY94-8862 )" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hirohata Naika Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hirohata Naika Clinic". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hirohata Naika Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hirohata Naika Clinic, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".